In our effort to make prescription drug use safer we at the TI are constantly on the alert for what is happening in the wider BC health system. While patients are often told to “take charge...
In Therapeutics Letter 136, just published last week, we ask a question some might find provocative: "How do YOU respond to Conflicts of Interest?" In professional education sessions, we might all be accustomed to the standard...
Statins and a Patient’s Perspective on Informed Decision-making Occasionally people read our Therapeutics Letters and contact us to share their experiences. These anecdotes are not systematically-reviewed evidence, but they sometimes give us insight to the dynamics...
A study published recently in PLOS One finds that cancer is increased with cumulative exposure to angiotensin-receptor blockers (ARBs). The authors carried out a meta-regression analysis, including 15 randomized clinical trials, zeroing in on cumulative exposure...